B
Blue Health Intelligence(BHI)
Accesses the industry’s comprehensive, conformed healthcare database of integrated medical and pharmacy claims
About Blue Health Intelligence(BHI)
Blue Health Intelligence (BHI), the trade name for Health Intelligence Company, LLC, operates as a data and analytics firm within the healthcare sector. It was established in 2010 and spun off as a separate business from the Blue Cross and Blue Shield Association (BCBSA) in 2011 with over $28 million in funding. The company is privately owned by the BCBSA and 17 Blue Cross Blue Shield (BCBS) plans. In January 2013, BHI acquired Intelimedix, a healthcare analytics firm, to expand its capabilities and create an "Informatics Center of Excellence" for BCBS companies.
BHI's business revolves around leveraging its extensive healthcare data to provide analytics and insights. The company holds one of the industry's largest and most comprehensive comparative claims databases, containing de-identified medical and pharmacy claims from over 190 million Americans. This data is utilized to build predictive models and analytical solutions that help healthcare organizations identify at-risk patients, manage care, and understand medical trends. The company's business model is centered on providing these data-driven insights as a service to a range of clients, including health plans (both Blue and non-Blue), employers, providers, and medical device companies.
The firm offers a suite of products and services designed to improve outcomes and reduce costs. These include plan and employer reporting, trend analysis, and performance benchmarking. Specific solutions like the High Cost Predictor Algorithm (HCPA) use machine learning to identify members who are likely to incur very high annual healthcare costs, enabling early intervention. BHI also provides tools for transparency analytics, provider analytics to build high-performing networks, and risk adjustment solutions for Medicare Advantage and ACA populations. Their services are delivered through software-as-a-service (SaaS) platforms and in-depth consulting provided by a team of data analysts, clinicians, and IT experts. From May 2011 to March 2022, the company was led by CEO Swati Abbott, who has an extensive background in healthcare predictive analytics, having previously served as President of MEDai, Inc. Since 2022, the CEO has been Bob Darin, a national expert in applying analytics at scale who previously served as Chief Analytics Officer and Chief Data Officer at CVS Health.
Source: Dealroom company dataAt a glance
- Outcome tier
- Colt$25–100M revenue
News
Open roles
Blue Health Intelligence(BHI) in the Chicago ecosystem
The Blue Health Intelligence(BHI) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Blue Health Intelligence(BHI) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Blue Health Intelligence(BHI) on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

